Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil
PLOS ONE · 13.04.2023 · 18 (4) · e0283774
DOI: 10.1371/journal.pone.0283774 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.04.2023. Verfasst von Cezar Vinícius Würdig Riche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Cross Infection, Bacteremia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
This study aimed to evaluate the epidemiology and 30-day mortality of adult patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. We retrospectively reviewed the demographic and clinical data of adult patients with S . aureus bloodstream infections (BSI), admitted to a tertiary public teaching medical center in Porto Alegre, Southern Brazil, from January 2014 to December 2019. A total of 928 patients with S . aureus BSI were identified in the study period (68.5 per 100,000 patient-years), and the proportion of MRSA isolates was 22% (19–27%). Thus, 199 patients were included in the analyses. The median age was 62 (IQR: 51–74) years, Charlson Comorbidity Index (CCI) median was 5 (IQR: 3–6), the Pitt bacteremia score (PBS) median was 1 (IQR: 1–4), and the most common site of infection was skin and soft tissue (26%). Most infections were hospital-acquired (54%), empirical anti-MRSA treatment was initiated in 34% of the cases, and in 44% vancomycin minimum inhibitory concentration was 1.5mg/L or above. Sixty-two (31.2%) patients died up to 30 days after the bacteremia episode. Patients with more comorbid conditions (higher CCI; aOR 1.222, p = 0.006) and a more severe presentation (higher PBS; aOR 1.726, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
- Serviço de Controle de Infecção, Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brazil.
- School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
- Instituto de Microbiologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
ORCID-Profile: Cezar Vinícius Würdig Riche, Mario Ramirez, Cícero Armídio Gomes Dias
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Riche, C. V. W., Cassol, R., Falci, D. R., Ramirez, M., & Dias, C. A. G. (2023). Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil. PLOS ONE, 18(4), e0283774. https://doi.org/10.1371/journal.pone.0283774
Vancouver
Riche CVW, Cassol R, Falci DR, Ramirez M, Dias CAG. Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil. PLOS ONE. 2023;18(4):e0283774. doi:10.1371/journal.pone.0283774
BibTeX
@article{Riche2023,
author = {Riche, Cezar Vinícius Würdig and Cassol, Renato and Falci, Diego Rodrigues and Ramirez, Mario and Dias, Cícero Armídio Gomes},
title = {Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {4},
pages = {e0283774},
doi = {10.1371/journal.pone.0283774}
}
EUVIMED